BioSpace News Archive

Nanomerics Ltd., a private speciality pharmaceutical company, announced that the Company had received an Innovation Passport from the UK Medicines and Healthcare Products Regulatory Agency for its lead asset - OC134.

ProKidney Corp., a leading late clinical-stage cellular therapeutics company focused on chronic kidney disease, announced the appointment of Glenn Schulman, PharmD, MPH, as Senior Vice President of Investor Relations.

Bionomics Limited announced that it will participate in the following upcoming investor conferences in September.

Vivani Medical, Inc., formerly Second Sight Medical, Inc., announced that trading of the Company’s common stock on The Nasdaq Capital Market under the symbol “VANI”.

Isarna Therapeutics will present an update from its ISTH0036 clinical development program and the ongoing BETTER Study at the EURETINA meeting in Hamburg, Germany on September 1st, 2022.

Burning Rock Biotech Limited, a company focused on the application of next generation sequencing technology in the field of precision oncology, reported financial results for the three months ended June 30, 2022.

Orexo AB, which develops improved pharmaceuticals and evidence-based digital therapeutics primarily targeting the US market where its commercial organization is located, announces the company will participate in Pareto Securities’ 13th Annual Healthcare Conference, that takes place on September 7-8, 2022, at Sergel Hub, Sveavägen 10 A, Stockholm, Sweden.

JenaValve Technology, Inc., developer and manufacturer of differentiated transcatheter aortic valve replacement systems, announced that it has completed the initial closing of a $100 million Series C financing.

ImmunoGen, Inc. provided an update on the pivotal Phase 2 CADENZA study of pivekimab sunirine in blastic plasmacytoid dendritic cell neoplasm.